Naveen Pemmaraju, MD; The University of Texas MD Anderson Cancer Center; 5Live #ASH21
7:42
Key insights from the 2021 Annual Hematology meeting in Atlanta
Myeloproliferative Neoplasm
Naveen Pemmaraju, MD; The University of Texas MD Anderson Cancer Center; 5Live #ASH21
Key insights from the 2021 Annual Hematology meeting in Atlanta
Myeloproliferative Neoplasm Similar Videos
Similar Videos
-
Therapeutic Options for Patients with JAK-Inhibitor–Naïve Myelofibrosis_Naveen Pemmaraju, MD
21:38
-
Podium to Practice: Recent Updates on the Treatment of Myeloproliferative Neoplasms – Highlights from the 2021 Hematology Annual Meeting_John Mascarenhas, MD_Alessandro Vannucchi, MD
30:03
-
New treatments for MPNs, CML, and systemic mastocytosis_Ellen Ritchie, MD; #BeyondTheCongress
17:44
